Image

Gene Therapy Trials for Hemophilia A: Where We Are and What Comes Next

Here’s what we’ll discuss
  • Icon

    A general overview of the clinical trial process

  • Icon

    Details on the design of the BioMarin gene therapy clinical trial program for hemophilia A (BMN 270) and its current progress

  • Icon

    BioMarin's approach to advocacy for the hemophilia community

WATCH THE VIDEO
Interested in expanding your knowledge?

Sign up for information about upcoming events, new resources, and the latest from BioMarin.

Are you a U.S. resident?

This content is intended for US participants only.